Literature DB >> 17764977

Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.

Alexander Hammers1, Marie-Claude Asselin, Federico E Turkheimer, Rainer Hinz, Safiye Osman, Gary Hotton, David J Brooks, John S Duncan, Matthias J Koepp.   

Abstract

[(11)C]diprenorphine (DPN) is a non-subtype selective opioid receptor PET ligand with slow kinetics and no region devoid of specific binding. Parametric maps are desirable but have to overcome high noise at the voxel level. We obtained parameter values, parametric map image quality, test-retest reproducibility and reliability (using intraclass correlation coefficients (ICCs)) for conventional spectral analysis and a derived method (rank shaping), compared them with values obtained through sampling of volumes of interest (VOIs) on the dynamic data sets and tested whether smaller amounts of radioactivity injected maintained reliability. Ten subjects were injected twice with either approximately 185 MBq or approximately 135 MBq of [(11)C]DPN, followed by dynamic PET for 90 min. Data were movement corrected with a frame-to-frame co-registration method. Arterial plasma input functions corrected for radiolabelled metabolites were created. There was no overall effect of movement correction except for one subject with substantial movement whose test-retest differences decreased by approximately 50%. Actual parametric values depended heavily on the cutoff for slow frequencies (between 0.0008 s(-1) and 0.00063 s(-1)). Image quality was satisfactory for restricted base ranges when using conventional spectral analysis. The rank shaping method allowed maximising of this range but had similar bias. VOI-based methods had the widest dynamic range between regions. Average percentage test-retest differences were smallest for the parametric maps with restricted base ranges; similarly ICCs were highest for these (up to 0.86) but unacceptably low for VOI-derived VD estimates at the low doses of injected radioactivity (0.24/0.04). Our data can inform the choice of methodology for a given biological problem.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764977     DOI: 10.1016/j.neuroimage.2007.06.035

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  16 in total

Review 1.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

2.  Improved models for plasma radiometabolite correction and their impact on kinetic quantification in PET studies.

Authors:  Matteo Tonietto; Mattia Veronese; Gaia Rizzo; Paolo Zanotti-Fregonara; Talakad G Lohith; Masahiro Fujita; Sami S Zoghbi; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-15       Impact factor: 6.200

3.  [18 F]Nifene test-retest reproducibility in first-in-human imaging of α4β2* nicotinic acetylcholine receptors.

Authors:  Patrick J Lao; Tobey J Betthauser; Dana L Tudorascu; Todd E Barnhart; Ansel T Hillmer; Charles K Stone; Jogeshwar Mukherjee; Bradley T Christian
Journal:  Synapse       Date:  2017-04-26       Impact factor: 2.562

4.  A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method.

Authors:  Mattia Veronese; Alessandra Bertoldo; Shrinivas Bishu; Aaron Unterman; Giampaolo Tomasi; Carolyn Beebe Smith; Kathleen C Schmidt
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-03       Impact factor: 6.200

5.  Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.

Authors:  Lisbeth Marner; Gitte M Knudsen; Steven Haugbøl; Søren Holm; William Baaré; Steen G Hasselbalch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

6.  The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study.

Authors:  Gaia Rizzo; Mattia Veronese; Rolf A Heckemann; Sudhakar Selvaraj; Oliver D Howes; Alexander Hammers; Federico E Turkheimer; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

7.  Striatal opioid receptor availability is related to acute and chronic pain perception in arthritis: does opioid adaptation increase resilience to chronic pain?

Authors:  Christopher A Brown; Julian Matthews; Michael Fairclough; Adam McMahon; Elizabeth Barnett; Ali Al-Kaysi; Wael El-Deredy; Anthony K P Jones
Journal:  Pain       Date:  2015-11       Impact factor: 7.926

8.  Parametric Mapping for TSPO PET Imaging with Spectral Analysis Impulsive Response Function.

Authors:  Mattia Veronese; Marcello Tuosto; Tiago Reis Marques; Oliver Howes; Belen Pascual; Meixiang Yu; Joseph C Masdeu; Federico Turkheimer; Alessandra Bertoldo; Paolo Zanotti-Fregonara
Journal:  Mol Imaging Biol       Date:  2021-01-21       Impact factor: 3.488

9.  A Functional Approach to Deconvolve Dynamic Neuroimaging Data.

Authors:  Ci-Ren Jiang; John A D Aston; Jane-Ling Wang
Journal:  J Am Stat Assoc       Date:  2016-05-05       Impact factor: 5.033

10.  Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.

Authors:  Daniela A Riaño Barros; Colm J McGinnity; Lula Rosso; Rolf A Heckemann; Oliver D Howes; David J Brooks; John S Duncan; Federico E Turkheimer; Matthias J Koepp; Alexander Hammers
Journal:  Neuroimage       Date:  2014-04-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.